Ambulatory Prolapse Surgery (PROLAMBU)

August 27, 2025 updated by: Hospices Civils de Lyon

Ambulatory Prolapse Surgery: Feasibility Study

Day surgery is performed in the same way as in full hospital admission, allowing same-day discharge without increased risk. It provides many grounds for patient satisfaction. Progress in surgical and anesthesia techniques now allows this form of management to be developed and prioritized.

Day-care surgery for prolapse has been little studied. The present study is intended to help extend its future implementation, the primary objective being to assess the feasibility of the day-care approach in prolapse surgery. The secondary objectives are to study criteria of non-eligibility for day-care prolapse surgery, reasons for patients' refusal, causes of failure, predictive factors for failure, patient satisfaction, postoperative complications, 2-year anatomic and functional results, pain, quality of life and sexuality, and postoperative onset of dyspareunia and urinary incontinence.

The design is for a prospective non-randomized study conducted in 3 gynecologic surgery sites managed by the Lyon hospitals board (Hospices Civils de Lyon).

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bron, France, 69500
        • Hôpital Femme Mère Enfant

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Stage III or IV anterior genital prolapse (cystocele) on the Pelvic Organ Prolapse Quantification (POP-Q) classification and/or vaginal floor prolapse
  • Vaginal approach with prosthetic reinforcement planned
  • Patient eligible for day-surgery
  • Patient consenting to participate
  • Informed and signed consent

Exclusion Criteria:

  • Interview revealing disorder entailing unacceptable risk of postoperative complications: coagulation disorder, immune system disorder, progressive disease, etc.
  • Patient with ≥1 ineligibility criterion for day-surgery
  • Impaired lower-limb range of motion preventing positioning for surgery
  • Pregnancy, ongoing or planned during the study period
  • Progressive or latent infection or signs of tissue necrosis on clinical examination
  • Non-controlled diabetes (glycated hemoglobin >8%)
  • Treatment impacting immune response (immunomodulators), ongoing or within previous month
  • History of pelvic region radiation therapy, at any time
  • History of pelvic cancer
  • Non-controlled progressive spinal pathology
  • Known hypersensitivity to one of the implant components (polypropylene)
  • Inability to understand information provided
  • Not covered by a national health insurance scheme, prisoner or under administrative supervision.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Genital prolapse
Single arm: i.e., all patients
day-care surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of patient with success for ambulatory surgery
Time Frame: Day 1 (postoperative)
Number of prolapse surgery patients actually managed on a day-care basis
Day 1 (postoperative)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
causes of non-eligibility for day-care management analysis
Time Frame: Day 1 (before surgery)
list and percentage
Day 1 (before surgery)
reasons for patients' refusal analysis
Time Frame: Day 1 (before surgery)
list and percentage
Day 1 (before surgery)
causes of failure of day-surgery analysis
Time Frame: Day 1 (postoperative)
list and percentage
Day 1 (postoperative)
Number of patients satisfied with day-surgery
Time Frame: Day 1 (postoperative)
Day 1 (postoperative)
Post-surgery complications
Time Frame: Day 1 (postoperative), month 1, year 1 and year 2
number and percentage of cases of infection, hematoma, urinary retention, healing defect (exposure or erosion), retraction, death
Day 1 (postoperative), month 1, year 1 and year 2
Number of prolapse correction failure
Time Frame: month 1, year 1 and year 2
month 1, year 1 and year 2
pain score analysis
Time Frame: month 1, year 1 and year 2
0 to 10 scale
month 1, year 1 and year 2
quality of life scores analysis
Time Frame: month 1, year 1 and year 2
SF- 12 Short Form (12) Health Survey PFDI-20 : Pelvic Floor Distress Inventory PFIQ-7 : Pelvic Floor Impact Questionnaire PGI-I : Patient Global Impression of Improvement
month 1, year 1 and year 2
quality of life scores analysis
Time Frame: month 1, year 1 and year 2
SF- 12 Short Form (12) Health Survey
month 1, year 1 and year 2
quality of life scores analysis
Time Frame: month 1, year 1 and year 2
PFDI-20 : Pelvic Floor Distress Inventory
month 1, year 1 and year 2
quality of life scores analysis
Time Frame: month 1, year 1 and year 2
PGI-I : Patient Global Impression of Improvement
month 1, year 1 and year 2
quality of life scores analysis
Time Frame: month 1, year 1 and year 2
PFIQ-7 : Pelvic Floor Impact Questionnaire
month 1, year 1 and year 2
sexuality score analysis
Time Frame: month 1, year 1 and year 2
PISQ-12 questionnaire
month 1, year 1 and year 2
percentage dyspareunia
Time Frame: month 1, year 1 and year 2
month 1, year 1 and year 2
number of onset of urinary incontinence
Time Frame: month 1, year 1 and year 2
month 1, year 1 and year 2

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 15, 2015

Primary Completion (Actual)

September 3, 2019

Study Completion (Actual)

September 3, 2019

Study Registration Dates

First Submitted

October 19, 2015

First Submitted That Met QC Criteria

October 22, 2015

First Posted (Estimated)

October 23, 2015

Study Record Updates

Last Update Posted (Estimated)

September 4, 2025

Last Update Submitted That Met QC Criteria

August 27, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 69HCL15_0215
  • 2015-A00599-40 (Other Identifier: ID-RCB)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Genital Prolapse

Clinical Trials on day-care surgery

Subscribe